A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

Clinical trial NCT02591732 · COMPLETED

Trial details

NCT number: NCT02591732
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Anticoagulation

Start date: 2014-08-01
Primary completion: 2015-06-01
Enrollment: 52178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.